Cancer Research CTRC-AACR San Antonio Breast Cancer Symposium  Cancer Health Disparities Conference 2009
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Cancer Research Clinical Cancer Research
Cancer Epidemiology Biomarkers & Prevention Molecular Cancer Therapeutics
Molecular Cancer Research Cancer Prevention Research
Cancer Prevention Journals Portal Cancer Reviews Online
Annual Meeting Education Book Meeting Abstracts Online

[Cancer Research 34, 1429-1434, June 1, 1974]
© 1974 American Association for Cancer Research

This Article
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Verbin, R. S.
Right arrow Articles by Farber, E.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Verbin, R. S.
Right arrow Articles by Farber, E.

The Action of Nitrogen Mustard in Synchronized Intestinal Crypt Cells in Vivo1

Robert S. Verbin, Gloria Diluiso and Emmanuel Farber2

Departments of Pathology, University of Pittsburgh Schools of Medicine and Dental Medicine, Pittsburgh, Pennsylvania 15261

The exposure to nitrogen mustard of synchronized crypt epithelial cells during various stages of the proliferative cycle induced distinctive morphological alterations in the intestinal mucosa. These structural abberrations were virtually identical regardless of the position of the crypt epithelial cells within the generation cycle at the time of drug administration and were indistinguishable from those induced in asynchronous populations. These findings indicate that nitrogen mustard can exert its cytotoxic effects not only throughout interphase but during the stage of nuclear division as well.

1 This research was supported by Grant CA-11390 from the National Cancer Institute.

2 Present address: Fels Research Institute, Temple University School of Medicine, Philadelphia, Pa. 19140.

Received 9/21/73. Accepted 3/ 5/74.







HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Cancer Research Clinical Cancer Research
Cancer Epidemiology Biomarkers & Prevention Molecular Cancer Therapeutics
Molecular Cancer Research Cancer Prevention Research
Cancer Prevention Journals Portal Cancer Reviews Online
Annual Meeting Education Book Meeting Abstracts Online
Copyright © 1974 by the American Association for Cancer Research.